Home | Knowledge | Science and guidelines

Science and guidelines

Search

Guidelines

Overview of current national and international guidelines.

Children and adolescents

It is important for children to receive treatment at an early age (starting at age 6).

Prevalence

FH affects about 1 in 300 people.

Risks Associated with FH

Risk is determined on an individual basis in consultation with the treating professional.

Treatment

There are many developments in the field of treatment.

DLCN score

The DLCN score helps healthcare providers assess the likelihood of familial hypercholesterolemia (FH) based on clinical data, family history, and cholesterol levels.

Cholesterol reference values

A tool providing reference values for cholesterol in children and adults without cardiovascular disease, to assist in the interpretation of lipid profiles.

LDL-C calculator

A calculator to estimate (untreated) LDL cholesterol in FH based on the lipid-lowering therapy being used and to identify extremely high levels in a timely manner.

Science and guidelines

Guidelines

Children and adolescents

Prevalence

Risks Associated with FH

Treatment

DLCN score

Cholesterol reference values

LDL-C calculator

FH Healthcare in the Region